RBD- SPECIFIC TH1 RESPONSES ARE ASSOCIATED WITH VACCINE-INDUCED PROTECTION AGAINST SARS-COV-2 INFECTION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies

The SARS-CoV-2 pandemic still Parts represents a threat for immunosuppressed and hematological malignancy (HM) bearing patients, causing increased morbidity and mortality.Given the low anti-SARSCoV-2 IgG titers post-vaccination, the COVID-19 threat prompted the prophylactic use of engineered anti-SARS-CoV-2 monoclonal antibodies.In addition, potent

read more